Creo Medical (GB:CREO) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Creo Medical Group PLC has announced the appointment of Kevin Crofton and Brent Boucher as new independent Non-Executive Directors, with Crofton succeeding Charles Spicer as Chair, effective from July 1, 2024. The change comes as the company, known for its minimally invasive surgical endoscopy devices, transitions towards a new phase of commercial growth. The new directors bring a wealth of experience, with Crofton having a strong track record in the technology sector and Boucher in medical device commercialization.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
